Skip to main content

Science program for blind/low vision kids

I

I'm just posting this reminder about this program.

This is  
our LAST CHANCE to apply for this exciting new program!   APPLICATION DEADLINE APRIL 1ST 
This pioneer program will focus on fostering a sense of innovation and autonomy in young students by allowing them to determine their course of study during the week of the program. Students will ultimately focus on one investigation which they will showcase at the Innovators Expo. However, multiple branches of science will be explored throughout the program through extension activities.
 
A unique component of NFB Project Innovation is how it will serve two age groups simultaneously. The first of these two groups will be comprised of students in grades 3-6 (ages 7-11).  This group, called Junior Innovators, will stay at the NFBJI for three days, July 25-29.** Twenty blind students will be accepted into this group. 
 
The high school students, called Senior Innovators, will serve as junior advisors. Students in grades 9-12 (ages 14-18) are eligible to apply to be a Senior Innovator.  They will not only participate in this science program but will model blindness skills, scientific investigation skills, and techniques to their younger counterparts. The Senior Innovators will stay at the NFBJI for four days, July 24-29, 2012.**  Ten blind students will be accepted into this group.
 
There will be a $250 fee for each Junior Innovator/Chaperone pair and a $250 fee for each Senior Innovator attending. Other expenses, such as the cost of travel, room, board, and program materials, will be covered by the NFB Jernigan Institute for all students and student/chaperone pairs.
 
 
Apply now at http://www.nfb.org/projectinnovation.  More information is available at www.blindscience.org. Applications are due by April 1, 2012. For more information, please contact Abby Bispo at 410-659-9314, extension 2312 or by email at abispo@nfb.org
 
*Exact program dates differ based on grade level
**Date range reflects travel time.
 

Labels:

Comments

Post a Comment

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for
1 comment
Read more

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.
Post a Comment
Read more

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria
Post a Comment
Read more